RANDOM [resa]    
Phase II Study [resa]    
placebo [topp]    
Plus [qlco]    
Best [qlco]    
Supportive care [topp]    
Second Line Treatment [topp]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
Plus [qlco]    
Best [qlco]    
Supportive care [topp]    
fail [ftcn]    
To [qlco]    
Meet [idcn]    
Primary Endpoint [irda]    
Overall [inpr]    
Survival [acty]    
Second Line Treatment [topp]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
RANDOM [resa]    
Phase II Study [resa]    
Arm [blor]    
Show [inpr]    
Improved [qlco]    
Progression-Free Survival [qnco]    
Time to Progression [tmco]    
Tumor [neop]    
Clinical [qlco]    
Benefit [qnco]    
Rate [acty]    
Compare [acty]    
placebo [topp]    
Arm [blor]    
accept [qlco]    
Safeties [hcpp]    
Profile [lbpr]    
Background [cnce]    
Efficacy [qlco]    
Safeties [hcpp]    
Potential [qlco]    
Inhibitor [qlco]    
Combination [qlco]    
Best [qlco]    
Supportive care [topp]    
Evaluable [ftcn]    
Global [spco]    
RANDOM [resa]    
placebo-controlled [resa]    
Phase II Trial [resa]    
patient [podg]    
Local [spco]    
Advance [qlco]    
Metastatic Carcinoma [neop]    
Hepatocellular [qlco]    
patient [podg]    
Method [inpr]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Child [aggp]    
Class [inpr]    
progress [ftcn]    
Intolerance [ftcn]    
One [qnco]    
Prior Therapy [clna]    
Stratified [qlco]    
Tumor invasion [fndg]    
Present Absent [cnce]    
Extrahepatic [spco]    
Spread [qlco]    
vascular [bpoc]    
Invasion [fndg]    
Region [geoa]    
Asian [popg]    
Non [ftcn]    
RANDOM [resa]    
+2 [qnco]    
1+ [qnco]    
Best [qlco]    
Supportive care [topp]    
Start [tmco]    
Dose [qnco]    
mg% [qnco]    
Twice daily [tmco]    
placebo [topp]    
Best [qlco]    
Supportive care [topp]    
Primary Endpoint [irda]    
Overall [inpr]    
Survival [acty]    
Result [ftcn]    
Estimate [qnco]    
Hazard Ratio [qnco]    
Overall [inpr]    
Survival [acty]    
Confidence Interval [qnco]    
one side [spco]    
Stratified [qlco]    
Best [qlco]    
Supportive care [topp]    
placebo [topp]    
Best [qlco]    
Supportive care [topp]    
68 [inpr]    
median [spco]    
Confidence Interval [qnco]    
>5 [qnco]    
month [tmco]    
Result [ftcn]    
subgroup [virs]    
Analysis [lbpr]    
Asian [popg]    
{Non-patient} [clna]    
Asian [popg]    
Presence [topp]    
absence [qnco]    
Tumor invasion [fndg]    
CONSIST [idcn]    
Overall [inpr]    
Population [qnco]    
Improved [cnce]    
Best [qlco]    
Supportive care [topp]    
Observation [ftcn]    
secondary [neop]    
Efficacy [qlco]    
End Point [qlco]    
Analysis [lbpr]    
Progression-Free Survival [qnco]    
Time to Progression [tmco]    
Tumor [neop]    
Clinical [qlco]    
Benefit [qnco]    
Rate [acty]    
Retain [ftcn]    
Asian [popg]    
patient [podg]    
subgroup [virs]    
Analysis [lbpr]    
Overall Response [fndg]    
Rate [acty]    
Not [ftcn]    
treatment [topp]    
Patient Reported Outcome [inpr]    
placebo [topp]    
Best [qlco]    
Supportive care [topp]    
Most [qnco]    
Common [qnco]    
causality [ftcn]    
Adverse event [fndg]    
Best [qlco]    
Supportive care [topp]    
Diarrhea [sosy]    
Hypertension [dsyn]    
Decreased appetite [sosy]    
baseline [bodm]    
Serum [bdsu]    
Analysis [lbpr]    
Identifiable [qlco]    
Potential [qlco]    
New [tmco]    
prognostic [inpr]    
Predictability [qlco]    
Stroma [bpoc]    
derivation [qlco]    
Factor [ftcn]    
Factor [ftcn]    
Survival [acty]    
Conclusion [idcn]    
Best [qlco]    
Supportive care [topp]    
Not [ftcn]    
Overall [inpr]    
Survival [acty]    
placebo [topp]    
Best [qlco]    
Supportive care [topp]    
Overall [inpr]    
Population [qnco]    
Stratification [resa]    
subgroup [virs]    
Best [qlco]    
Supportive care [topp]    
Result [ftcn]    
Long [qlco]    
Progression-Free Survival [qnco]    
Time to Progression [tmco]    
Tumor [neop]    
High [qlco]    
Clinical [qlco]    
Benefit [qnco]    
Rate [acty]    
accept [qlco]    
toxic [qlco]    
patient [podg]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
Trial [resa]    
Registration [hlca]    
GOV [gngm]    
